GSK-110021: Efficacy of GSK Biologicals’ candidate malaria vaccine (257049) against malaria disease caused by P. falciparum infection in infants and children in Africa
GSK-BEP114001: Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
GSK-200599: Extension to study MALARIA-055 PRI (NCT00866619) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine (SB257049) in infants and children in Africa